SNP and gene associations use P < 10⁻¹⁰. Change threshold · Counts cover features with indexed GWAS data; — means unavailable.

GeneAssociated metabolitesResearch resources

GENE DETAIL · Glycine max

Glyma.14G149300

Description hypothetical protein

Gene interval Chr14:32235308–32258014 (+), Wm82.a2.v1 · 1-based inclusive

Arabidopsis ortholog NA

Genome context

Explore gene–feature relationships using Overlap or Within ±5 kb. Scope definitions

Explore research resources ↓
Associated metabolite features2225Overlap
Maximum supporting SNP records3
Features with ≥2 supporting SNP records2224

Supporting SNP records satisfy P < 10⁻¹⁰ and the selected positional scope. Counts cover the 30345 features with indexed GWAS data.

Additional descriptive statistic

Mean supporting SNP records per associated feature: 2.0162.

Research resources

Follow this gene identifier to compare annotations, examine protein function and find supporting literature.

These links search the displayed identifier. Check the organism, genome assembly and evidence in the destination record.

Compare gene models, expression and reported orthologs

SoyBase gene-name translator ↗SoyBase expression resources ↗Legume Information System ↗

Use expression and ortholog evidence to develop a testable hypothesis. The linked resources do not establish the function of this soybean gene in the measured samples.

Associated metabolites

Browse associated features and open their GWAS evidence or compound candidates.

2225 matching features · page 108 of 223

Metabolite IDCandidate annotationDeionized mass (Da)Supporting SNP recordsMinimum P
P25130 Hypodematine 247.0999 29.655e-11
P25131 Deutziol 348.1407 22.681e-11
P25172 Validamycin G 513.2035 23.281e-11
P25186 7,10,13,16,19-Docosapentaynoic acid 320.1775 21.493e-12
P25202 Proglumide 334.1889 22.727e-12
P25279 No candidate annotation 323.6291 25.127e-14
P25341 Trifenmorph 329.1779 26.707e-11
P25358 Scutebarbatine E 571.2292 27.505e-12
P25374 Bisnor-(+)-S-145 349.1461 22.029e-11
P25398 SC-57666 316.0926 25.05e-15